Interleukin Genetics reports increased Q1 revenues

Interleukin Genetics reported an increase in revenues for the first quarter of 2016.

For the quarter (end-March 31), the company reported revenues of $961,000, up 38% compared with $403,000 from the same quarter in 2015, according to the company. Net loss for the first quarter was $1.5 million, down from $1.8 million in the same period of 2015.

The company produces the PerioPredict genetic test.